Biological Warfare — A Growing Healthcare Concern

Christopher GW Cieslak TJ Pavlin JA Eitzen EM Jr. Biological warfare. A historical perspective. JAMA 1997;278: 412–7.

Proceedings of the National Symposium on Medical and Public Health Response to Bioterrorism. Arlington, VA, February 16–17, 1999. Emerg Infect Dis 1999;5: 491–592.

Henderson DA . Weapons for the future. Lancet 1999;354 (Suppl):SIV64.

Henderson DA Inglesby TV Bartlett JG Ascher MS Eitzen E Jarhrling PB Smallpox as a biological weapon: Medical and public health management. JAMA 1999;281: 2127–37.

Update: Management of patients with suspected viral hemorrhagic fever — US. MMWR Morb Mortal Wkly Rep 1995;44: 475–9.

Brachman PS . Inhalation anthrax. Ann N Y Acad Sci 1980;353: 83–93.

Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices. Clin Toxicol 2001;39: 85–100.

Richards CF Burstein JL Waeckerle JF Hutson HR . Emergency physicians and biological terrorism. Ann Emerg Med 1999;34: 183–90.

Inglesby TV Henderson DA Bartlett JG Ascher MS Eitzen E Friedlander AM Anthrax as a biological weapon: Medical and public health management. JAMA 1999;281: 1735–45.

Inglesby TV Dennis DT Henderson DA Bartlett JG Ascher MS Eitzen E Plague as a biological weapon: Medical and public health management. JAMA 2000;283: 2281–90.

Arnon SS Schechter R Inglesby TV Henderson DA Bartlett JG Ascher MS Botulinum toxin as a biological weapon: Medical and public health management. JAMA 2001;285: 1059–70.

Dennis DT Inglesby TV Henderson DA Bartlett JG Ascher MS Eitzen E Tularemia as a biological weapon: Medical and public health management. JAMA 2001;285: 2763–73.

Kortepeter M Christopher G Cieslak T Culpepper R Darling R Pavlin J Medical management of biological casualties handbook. 4th ed. Washington, DC: US Army Medical Research Institute of Infectious Diseases, Feb. 2001.

Buttery CMG . Provision of public health services. In: Maxcy-Rosenau , ed. Public health and preventive medicine. East Norwalk, CT: Appleton & Lange, 1992:1113.

Malloy CD . A history of biological and chemical warfare and terrorism. J Public Health Manag Pract 2000;6: 30–7.

Olson KB . Aum Shinrikyo: Once and future threat. Emerg Infect Dis 1999;5: 513–6.

Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001;50: 889–93.

Federal response to acts of bioterrorism and chemical terrorism: a general overview. Washington, DC: Agency for Toxic Substances and Disease Registry, 2001: 1–4.

Biological and chemical terrorism: Strategic plan for preparedness and response. MMWR Morb Mortal Wkly Rep 2000;49(RR 4):1–14.

Owens RC Jr. Risk assessment for antimicrobial agent—induced QTc interval prolongation and torsades de pointes. Pharmacotherapy 2001;21: 301–19.

Package insert. Cipro (ciprofloxacin). West Haven, CT: Bayer Corporation, October 2000.